Selenium Sulfide

Manufacturer
Laser Pharmaceuticals, LLC
Effective date
2025-11-06
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
5
Source
full-release
Hydrated at
2026-05-31 22:04:37

Label at a glance#

ProductSelenium Sulfide
Active ingredientSELENIUM SULFIDE
Label structure18 sections

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Rx only

Selenium Sulfide 2.3% Shampoo

DESCRIPTION SECTION

DESCRIPTION: A liquid antiseborrheic, antifungal preparation for topical application. Each mL of Selenium Sulfide 2.3% Shampoo contains 23.0 mg selenium sulfide, and the following inactive ingredients: Alpha-tocopheryl acetate, ammonium lauryl sulfate, butylated hydroxytoluene, cetyl alcohol, cocamidopropyl betaine, disodium EDTA, D&C yellow #10, FD&C red #40, fragrance, methylparaben, panthenol, propylene glycol, propylparaben, purified water, pyrithione zinc, sodium thiosulfate, stearyl alcohol, triacetin, urea, and xanthan gum.

CLINICAL PHARMACOLOGY SECTION

CLINICAL PHARMACOLOGY: Selenium sulfide appears to have a cytostatic effect on cells of the epidermis and follicular epithelium, reducing corneocyte production.

PHARMACOKINETICS SECTION

PHARMACOKINETICS: The mechanism of action of topically applied selenium sulfide is not yet known.

INDICATIONS & USAGE SECTION

INDICATIONS & USAGE: A liquid antiseborrheic, antifungal preparation for the treatment of seborrheic dermatitis of the scalp, dandruff and tinea versicolor. Urea hydrates and is useful for conditions such as dry scalp.

CONTRAINDICATIONS SECTION

CONTRAINDICATIONS: Contraindicated in persons with known or suspected hypersensitivity to any of the listed ingredients.

WARNINGS SECTION

WARNINGS: For external use only. Not for ophthalmic use.

DO NOT USE ON BROKEN SKIN OR INFLAMED AREAS. If allergic reaction occurs, discontinue use. Avoid contact with eyes, genital areas and skin folds, as irritation and burning may result. If accidental contact occurs, rinse thoroughly with water. KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.

PRECAUTIONS SECTION

PRECAUTIONS: This medication is to be used as directed by a physician. Not to be used when inflammation or exudation is
present as increased absorption may occur.

CARCINOGENESIS

CARCINOGENESIS & MUTAGENESIS & IMPAIRMENT OF FERTILITY SECTION

CARCINOGENESIS: Dermal application of 25% and 50% solutions of 2.5% selenium sulfide lotion on mice over an 88-week
period indicated no carcinogenic effects.

USE IN PREGNANCY

PREGNANCY SECTION

USE IN PREGNANCY:
CATEGORY C

Animal reproduction studies have not been conducted with this medication. It is also not known whether this product can cause fetal harm when applied to the body surfaces of a pregnant woman or can affect reproduction capacity. Under ordinary circumstances, selenium sulfide 2.3% shampoo should not be used by pregnant women.

NURSING MOTHERS SECTION

NURSING MOTHERS: It is not known whether or not this drug is secreted in human milk. Because many drugs are secreted in human milk, caution should be exercised when this product is administered to a nursing woman.

PEDIATRIC USE SECTION

PEDIATRIC USE: Safety and effectiveness in children have not been established.

ADVERSE REACTIONS SECTION

ADVERSE REACTIONS: In decreasing order of severity: skin irritation; occasional reports of increase in normal hair loss; discoloration of hair (can be avoided or minimized by thorough rinsing of hair after treatment). As with other shampoos, oiliness or dryness of hair and scalp may occur.

OVERDOSAGE SECTION

OVERDOSAGE: There are no documented reports of serious toxicity in humans resulting from acute ingestion of selenium sulfide 2.3%
shampoo. However, acute toxicity studies in animals suggest that ingestion of large amounts could result in potential human toxicity.
Evacuation of the stomach contents should be considered in cases of acute oral ingestion.

DOSAGE & ADMINISTRATION SECTION

DOSAGE AND ADMINISTRATION:
SHAKE WELL BEFORE USING

For seborrheic dermatitis and dandruff: Generally 2 applications each week for 2 weeks will control symptoms. Subsequently, shampoo may be used less frequently – weekly, every 2 weeks, every 3 to 4 weeks or as directed by a physician. Should not be applied more frequently than necessary to maintain control.

For tinea versicolor: Wet skin and apply to affected areas. Massage gently into skin working to a full lather. Allow product to remain on
skin for 10 minutes, then rinse thoroughly. Repeat procedure once a day for seven days or as directed by a physician.

HOW SUPPLIED SECTION

HOW SUPPLIED: Selenium Sulfide 2.3% Shampoo is supplied in 6 fluid oz. (180 mL) bottles, NDC 16477-423-06. Store at 20° - 25°C (68° - 77°F), excursions permitted to 15° - 30°C (59° - 86°F). [See USP Controlled Room Temperature]. Brief exposure to temperatures up to 40°C (104°F) may be tolerated provided the mean kinetic temperature does not exceed 25°C (77°F); however, such exposure should be minimized. Protect from freezing.

All prescription substitutions and / or recommendations using this product shall be made subject to state and federal statutes as applicable. Please NOTE: This is not an Orange Book product and has not been subjected to FDA therapeutic equivalency or other equivalency testing. No representation is made as to generic status or bioequivalency.

Each person recommending a prescription substitution using this product shall make such recommendations based on each such person’s professional opinion and knowledge, upon evaluating the active ingredients, inactive ingredients (excipients) and other chemical information provided herein.

SPL UNCLASSIFIED SECTION

LASER

Manufactured for:
Laser Pharmaceuticals, LLC
Alpharetta, GA 30004
401167-01 Rev. 12/2024

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 16477-423-06

RX ONLY

Selenium

Sulfide

2.3%

Shampoo

6 fluid oz. (180 mL)

FOR TOPICAL USE OLY

NOT FOR OPHTHALMIC USE

LASER

LABEL 1LABEL 1

LABEL 2LABEL 2

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1436940selenium sulfide 2.3 % Medicated ShampooPSN5
1436940selenium sulfide 23 MG/ML Medicated ShampooSCD5
1436940selenium sulfide 2.3 % Medicated ShampooSY5

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
4073022c-5d5d-48f5-82ed-091ad146a4b2Product name120171211
9ffbd0ae-0bce-c086-b707-f0da5f8cd7c5Product name120150828

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
16477-423-06Selenium Sulfide180 mL in 1 BOTTLESHAMPOO1805

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDCBilling unitProduct NDCDailyMed indexing SPLSPL versionEffective
16477-423-06ML - Milliliter16477-423a62f9e7d-1e55-4b14-90b3-5097ec72eca212020-08-06

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
16477-42316477-423-06

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 20 matching rows.

Source Document#

Source XML

Older Hydrated Versions#

Version, Effective date, Source table
VersionEffective dateSourceHydrated
42025-04-23full-release2026-05-31 21:32:28

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Selenium SulfideSELENIUM SULFIDELaser Pharmaceuticals, LLCa72001ce-42a2-4708-e053-2995a90a75932025-11-06Warnings, Adverse reactionsExact identifier
ndc (package): 16477-423-06
ndc (product): 16477-423
ndc11 (package): 16477042306
spl id: 42f71665-ca72-5c41-e063-6394a90aaa74
spl set id: a72001ce-42a2-4708-e053-2995a90a7593

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.